ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » Pediatric Rheumatology Symposium 2017

Abstract Number: 86

The myositis-specific autoantibody and myositis-associated autoantibody phenotypes in Japanese juvenile idiopathic inflammatory myopathies

Takako Miyamae, Takayuki Kishi and Hisashi Yamanaka, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: Pediatric Rheumatology Symposium 2017

Keywords: juvenile dermatomyositis, juvenile myositis and myopathy

Session Information

Date: Thursday, May 18, 2017

Title: Clinical and Therapeutic Poster Session

Session Type: Abstract Submissions

Session Time: 5:30PM-7:00PM

Background/Purpose: Demographics,clinical features,and outcomes among myositis-specific autoantibody (MSA) and myositis-associated autoantibodies (MAAs) subgroups were assessed in children with juvenile idiopathic inflammatory myopathies (JIIM).

Methods: MSAs (anti-TIF-1, anti-MJ, anti-ARS , and anti-MDA-5), and MAAs were evaluated with above clinical information.

Results:  Among 12 JIIM children,MSAs and MAAs were detected in 9 (anti-TIF-1 (n=3), anti-MJ (n=3), anti-MDA-5 (n=2), and anti-ARS (n=1))and 1(anti-Ku). The other two were

negative.Eleven except anti-Ku positive child were consistent with juvenile dermatomyositis.Three patients with anti-TIF-1 mainly had skin

manifestations, 2 of the 3 were diagnosed clinically amyopathic dermatomyositis.Typical skin manifestations and myositis were noted in another 3 patients with anti-MJ.Of the two children with anti-MDA-5, one developed interstitial pneumonia successfully treated intravenous cyclophosphamide pulse therapy,and the other had arthritis intractable to conventional treatments and improved by adalimumab.

Conclusion: The MSAs were highly detected in JIIM patients. Myositis was most severe in anti-MJ positive patients, whereas the skin and extra-skeletal muscles symptoms were mainly noted in patients with anti-TIF-1 and anti-MDA-5.


Disclosure: T. Miyamae, None; T. Kishi, 2; H. Yamanaka, None.

To cite this abstract in AMA style:

Miyamae T, Kishi T, Yamanaka H. The myositis-specific autoantibody and myositis-associated autoantibody phenotypes in Japanese juvenile idiopathic inflammatory myopathies [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/the-myositis-specific-autoantibody-and-myositis-associated-autoantibody-phenotypes-in-japanese-juvenile-idiopathic-inflammatory-myopathies/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-myositis-specific-autoantibody-and-myositis-associated-autoantibody-phenotypes-in-japanese-juvenile-idiopathic-inflammatory-myopathies/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology